What is Psyonic?
Psyonic is a pioneering medical technology firm specializing in the development of advanced, accessible prosthetic devices. Originating from the University of Illinois at Urbana-Champaign, the company has gained significant industry traction through its flagship product, the Ability Hand. By leveraging cutting-edge robotics and sensory feedback systems, Psyonic aims to redefine the standard of care for amputees globally. The company operates at the intersection of human-computer interaction and biomechanical engineering, positioning itself as a disruptive force in the assistive technology market. Their commitment to affordability ensures that high-performance prostheses are no longer restricted to a niche demographic, but are instead becoming a viable reality for a broader patient population.
How much funding has Psyonic raised?
Psyonic has raised a total of $120K across 1 funding round:
Debt
$120K
Debt (2021): $120K with participation from PPP
Key Investors in Psyonic
PPP
Public-Private Partnership
What's next for Psyonic?
With this late-stage capital, Psyonic is poised to transition from a research-heavy startup to a commercial powerhouse. The strategic roadmap likely involves scaling manufacturing capabilities to meet rising demand and expanding distribution networks to reach underserved clinical markets. Furthermore, the infusion of resources will support ongoing R&D efforts to refine the Ability Hand, potentially integrating new sensory capabilities or expanding the product line to include lower-limb solutions. As the company matures, it will likely focus on securing deeper integration with healthcare providers and insurance networks, ensuring that its innovative devices become a standard component of post-amputation rehabilitation protocols. This growth phase is critical for establishing long-term market dominance in the competitive landscape of bionic prosthetics.
See full Psyonic company page
